Dora Hammerl
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 5
- Immunology 11
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 2
- Immune cells in cancer 2
- Immune Cell Function and Interaction 2
- Co-authors
- Reno Debets (12 shared papers)John W.M. Martens (7 shared papers)Marcel Smid (6 shared papers)A. Mieke Timmermans (1 shared paper)Stefan Sleijfer (1 shared paper)Marleen Kok (2 shared papers)Carolien H. M. van Deurzen (3 shared papers)Rebecca Wijers (4 shared papers)
- Journals
- Trends in Immunology (2 papers)Cancers (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)Scientific Reports (1 paper)
- Partner nations
- NetherlandsAustraliaUnited Kingdom
In The Last Decade
Dora Hammerl
9 papers receiving 401 citations
Peers
Comparison fields: 5 of 52
- Oncology 256
- Immunology 175
- Cancer Research 114
- Molecular Biology 151
- Pulmonary and Respiratory Medicine 47
Countries citing papers authored by Dora Hammerl
This map shows the geographic impact of Dora Hammerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Hammerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Hammerl more than expected).
Fields of papers citing papers by Dora Hammerl
This network shows the impact of papers produced by Dora Hammerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Hammerl. The network helps show where Dora Hammerl may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Hammerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 135 | |
| 2 | 2017 | 115 | |
| 3 | 2019 | 37 | |
| 4 | 2018 | 34 | |
| 5 | 2018 | 33 | |
| 6 | 2018 | 28 | |
| 7 | 2021 | 12 | |
| 8 | 2022 | 7 | |
| 9 | 2024 | 2 | |
| 10 | 2021 | 0 | |
| 11 | 2022 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2022 | 0 |
About Dora Hammerl
Dora Hammerl is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Hematology, having authored 13 papers that have together received 403 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers), Cancer Genomics and Diagnostics (3 papers), T-cell and B-cell Immunology (2 papers), CRISPR and Genetic Engineering (2 papers), Immune cells in cancer (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (256 citations), Immunology (175 citations), Cancer Research (114 citations), Molecular Biology (151 citations) and Pulmonary and Respiratory Medicine (47 citations). Dora Hammerl has collaborated with scholars based in Netherlands, Australia and United Kingdom. Frequent co-authors include Reno Debets, John W.M. Martens, Marcel Smid, A. Mieke Timmermans, Stefan Sleijfer, Marleen Kok, Carolien H. M. van Deurzen, Rebecca Wijers, Hayri E. Balcıoğlu and Renée Foekens. Their work appears in journals such as Trends in Immunology, Cancers, Clinical Cancer Research, The Journal of Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.